Difference between revisions of "Bioelectronic Devices for Electrical Stimulation"
Tag: Manual revert |
|||
Line 44: | Line 44: | ||
==Financial Model== | ==Financial Model== | ||
==References== | |||
XXX |
Revision as of 02:31, 12 October 2023
Technology Roadmap Sections and Deliverables
The Bioelectronic Devices for Electrical Stimulation [3BDES] is a level 3 technology roadmap focused around electrically stimulating biological systems (e.g., muscles, nerves, cells) for clinical purposes. A roadmap will be developed to explore the current status of the technology and the potential venues of progress from both a technical and business side.
Roadmap Overview
Bioelectronic Medicine is a novel approach that combines molecular medicine, neuroscience, and bioengineering to threaten and diagnose diseases and injuries. Bioelectronic devices can read and modulate electrical activity within the body. These devices open new possibilities and alternatives to diagnose and treat real-time diseases by using electrical pulses to restore health instead of chemical and biological drugs. In the literature, Bioelectronic Medicine can be found as neuromodulation, biostimulation, or electroceuticals. 1 2 3
The bioelectronic devices that delivers electrical stimulation and dominate the market are:
- Implantable Cardioverter Defibrillators (ICD)
- Cardiac Pacemakers (CP)
- Cochlear Implants (CI)
- Spinal Cord Stimulators (SCS)
- Deep Brain Stimulators (DBS)
- Sacral Nerve Stimulators (SNS)
- Transcutaneous Electrical Nerve Stimulators (TENS)
- Vagus Nerve Stimulators
Design Structure Matrix (DSM) Allocation
XXX
Roadmap Model using OPM
XXX
Figures of Merit
XXX
Alignment with Company Strategic Drivers
XXX
Positioning of Company vs. Competition
XXX
Technical Model
XXX
Financial Model
References
XXX